TAO-Towards Optimal (Neo)Adjuvant Systemic Therapy of Stage III Triple-negative Breast Cancer
Clinical trial NCT06931769 · RECRUITING
Trial details
- NCT number
- NCT06931769
- Sponsor
- The Netherlands Cancer Institute
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-11-06
- Primary completion
- 2029-07-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.